Cochlear Past Earnings Performance
Past criteria checks 5/6
Cochlear has been growing earnings at an average annual rate of 14.3%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 8.3% per year. Cochlear's return on equity is 19.7%, and it has net margins of 16.3%.
Key information
14.3%
Earnings growth rate
10.8%
EPS growth rate
Medical Equipment Industry Growth | 4.3% |
Revenue growth rate | 8.3% |
Return on equity | 19.7% |
Net Margin | 16.3% |
Next Earnings Update | 15 Aug 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Cochlear makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 2,149 | 350 | 874 | 270 |
30 Sep 23 | 2,043 | 326 | 842 | 257 |
30 Jun 23 | 1,936 | 301 | 810 | 245 |
31 Mar 23 | 1,824 | 281 | 768 | 230 |
31 Dec 22 | 1,713 | 261 | 725 | 215 |
30 Sep 22 | 1,681 | 275 | 691 | 213 |
30 Jun 22 | 1,648 | 289 | 658 | 211 |
31 Mar 22 | 1,612 | 273 | 628 | 208 |
31 Dec 21 | 1,575 | 257 | 597 | 205 |
30 Sep 21 | 1,536 | 291 | 579 | 200 |
30 Jun 21 | 1,498 | 324 | 560 | 195 |
31 Mar 21 | 1,403 | 82 | 549 | 187 |
31 Dec 20 | 1,308 | -160 | 537 | 180 |
30 Sep 20 | 1,314 | -199 | 550 | 182 |
30 Jun 20 | 1,321 | -238 | 564 | 185 |
31 Mar 20 | 1,400 | 34 | 569 | 188 |
31 Dec 19 | 1,479 | 306 | 574 | 190 |
30 Sep 19 | 1,453 | 291 | 560 | 187 |
30 Jun 19 | 1,427 | 277 | 546 | 184 |
31 Mar 19 | 1,422 | 270 | 535 | 180 |
31 Dec 18 | 1,418 | 264 | 525 | 175 |
30 Sep 18 | 1,391 | 255 | 510 | 172 |
30 Jun 18 | 1,364 | 246 | 494 | 168 |
31 Mar 18 | 1,329 | 234 | 475 | 164 |
31 Dec 17 | 1,294 | 223 | 456 | 160 |
30 Sep 17 | 1,274 | 223 | 444 | 156 |
30 Jun 17 | 1,254 | 224 | 432 | 152 |
31 Mar 17 | 1,218 | 215 | 426 | 149 |
31 Dec 16 | 1,182 | 206 | 420 | 146 |
30 Sep 16 | 1,156 | 198 | 412 | 146 |
30 Jun 16 | 1,131 | 189 | 403 | 145 |
31 Mar 16 | 1,088 | 179 | 383 | 142 |
31 Dec 15 | 1,045 | 168 | 362 | 138 |
30 Sep 15 | 986 | 157 | 341 | 133 |
30 Jun 15 | 926 | 146 | 320 | 128 |
31 Mar 15 | 899 | 145 | 308 | 126 |
31 Dec 14 | 872 | 144 | 296 | 124 |
30 Sep 14 | 839 | 119 | 288 | 126 |
30 Jun 14 | 805 | 94 | 279 | 128 |
31 Mar 14 | 769 | 85 | 267 | 129 |
31 Dec 13 | 732 | 76 | 256 | 130 |
30 Sep 13 | 742 | 104 | 248 | 127 |
30 Jun 13 | 753 | 133 | 241 | 125 |
Quality Earnings: OC5 has high quality earnings.
Growing Profit Margin: OC5's current net profit margins (16.3%) are higher than last year (15.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OC5's earnings have grown by 14.3% per year over the past 5 years.
Accelerating Growth: OC5's earnings growth over the past year (34%) exceeds its 5-year average (14.3% per year).
Earnings vs Industry: OC5 earnings growth over the past year (34%) exceeded the Medical Equipment industry -9.8%.
Return on Equity
High ROE: OC5's Return on Equity (19.7%) is considered low.